Natalia (Natasha) Muehlemann has over 20 years of experience in Life Sciences across several therapeutic areas, including intensive care, oncology, neurology, cardiovascular and metabolic diseases, and combines medical, statistics & data science and strategic expertise enhancing value through evidence generation, advanced analytics and stakeholders’ engagement. Natalia joined Cytel as VP, Strategic Consulting at Cytel, in 2020. At Cytel she is focusing on the integration of innovative adaptive frequentists, Bayesian designs, Machine Learning methods and RWE into comprehensive clinical development strategies that combine clinical, regulatory, market access and financial considerations. Prior to Cytel, Natalia was Global Category Head, Acute Care – Oncology – Devices at Nestle Health Sciences. Natalia acts as Expert Jury member for European Commission's Innovation Council and SMEs Executive Agency and other Investors forums. Natalia holds MD and MBA (IMD), Certifications in medical statistics (Stanford), data science (IBM), AI/ML (MIT) and executive education in Digital Transformation in Healthcare (HMS).